Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Klebsiella oxytoca testing
- Opportunistic pathogen monitoring
- gut microbiome dysbiosis assessment
What is Klebsiella oxytoca?
Klebsiella oxytoca is a gram-negative bacterium in the Klebsiella genus that can act as an opportunistic pathogen. It is normally present at low levels in some healthy guts but may cause clinical issues when overgrown or in immunocompromised individuals. Detected by shotgun metagenomic sequencing.
Why is Klebsiella oxytoca important?
Klebsiella oxytoca overgrowth has been associated with antibiotic-associated hemorrhagic colitis and other gut disturbances. Monitoring its relative abundance may provide early warning of microbiome imbalance, particularly after antibiotic use.
What insights will I get?
Your Klebsiella oxytoca level may indicate whether this organism is within a normal range or present at elevated levels that warrant attention. Discuss elevated detection with your care team, particularly alongside antibiotic resistance markers or other pathogen signals.





.avif)
.avif)

